Negotiating an international cannabis merger worth roughly $100 million is hard enough – but doing so during a global pandemic is downright daunting. That’s what Israel’s IM Cannabis had to do when it agreed in late 2020 to acquire To…
IM Cannabis
Israel’s IM Cannabis applies for Nasdaq listing
IM Cannabis Corp, a multinational medical marijuana company headquartered in Israel, has applied to list its shares on the Nasdaq stock exchange. IM Cannabis (IMC) is looking to join a growing number of medical marijuana companies whose shares trade on…
Israel medical cannabis patient count hits record as imports soar
The number of authorized medical cannabis patients in Israel has more than doubled in the past two years – topping 70,000 – despite persistent supply and regulatory challenges, according to new data from the Israeli Medical Cannabis Agency …